Skip to main content
Article
211 At-Anti-CD45 Radioimmunotherapy Can Replace TBI Prior to Haploidentical Bone Marrow Transplantation and Yield Long-Term Hematopoietic Engraftment
Blood (2014)
  • Johnnie J. Orozco, University of Washington
  • Aimee L. Kenoyer, Fred Hutchinson Cancer Research Center
  • Ethan R. Balkin, University of Washington
  • Donald K. Hamlin, University of Washington
  • D Scott Wilbur, University of Washington
  • Sofia H.L. Frost, Fred Hutchinson Cancer Research Center
  • Mark D. Hylarides, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, University of Washington
  • Brenda M. Sandmaier, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, University of Washington
  • Paul V. O'Donnell, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Publication Date
December 6, 2014
Citation Information
Johnnie J. Orozco, Aimee L. Kenoyer, Ethan R. Balkin, Donald K. Hamlin, et al.. "211 At-Anti-CD45 Radioimmunotherapy Can Replace TBI Prior to Haploidentical Bone Marrow Transplantation and Yield Long-Term Hematopoietic Engraftment" Blood Vol. 124 Iss. 21 (2014) p. 2417 - 2417
Available at: http://works.bepress.com/john-pagel/102/